Common Sleep Issues Reported During GLP-1 Treatment Patients on semaglutide describe several patterns: delayed sleep onset (taking longer to fall asleep), early morning waking (waking before desired time), and lighter overall sleep quality
Vyvanse may be a better fit if you want: A smoother, long-acting effect Once daily dosing with steady coverage An FDA-approved option for ADHD plus binge eating disorder Adderall may be a better fit if you want: More flexibility using Adderall IR A long-acting amphetamine option via Adderall XR Treatment that may also address narcolepsy (when appropriate) The best approach is usually a clinician-guided trial that tracks: ADHD symptom coverage (focus, inattention, impulsivity) Sleep and appetite changes Blood pressure and heart rate Mood and anxiety Timing needs (school/work schedule) FAQs Can I switch from Adderall to Vyvanse
the Take-Away A new class of diabetes and weight-loss drugs is drawing attention from researchers, and the early data on opioid addiction may be the most compelling signal yet
Ile 27 - From positions 3335 of GLP-1, each replacement with Ala increases the IC 50 about five-fold but somewhat decreases the EC 50
Additionally, the GLP-1R/glucose-dependent insulinotropic polypeptide receptor (GIPR) dual agonist tirzepatide can induce weight loss of 10%20%, and the results of the ongoing SURPASS-CVOT trial may provide more clarity on whether weight loss itself is an independent driver of CV protection (74)
